Ning Qu

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling.⚑
  2025 L1 No data access ⚑

1 assessed by us (0 reproduced) · 104 not yet assessed — every PubMed paper on record, linked below.

• Graph-based multi-modality network for axillary lymph node metastasis prediction in early-stage breast cancer ↗

  Computer Methods and Programs in Biomedicine · 2025 · PMID 40848561
  not yet assessed
• Developing a thyroid cancer differentiation state classification system using deep residual networks and metabolic signature profiling⚑

  npj Digital Medicine · 2025 · PMID 40993300
  L1 No data access ⚑
• Graph-Based Multi-Modality Network for Axillary Lymph Node Metastasis Prediction in Early-Stage Breast Cancer ↗

  SSRN Electronic Journal · 2025
  not yet assessed
• Supplementary Figure S3 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S4 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure S1 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S1 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S11 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure S6 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S3 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S8 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S2 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure s5 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S5 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure S2 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Methods S1 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Figure S4 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Data from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S7 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S10 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S6 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Supplementary Table S9 from An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  2025
  not yet assessed
• Multi‐pathway fusion network for early‐stage breast tumor segmentation from MRI ↗

  Medical Physics · 2025 · PMID 40317944
  not yet assessed
• Deep representation learning of chemical-induced transcriptional profile for phenotype-based drug discovery ↗

  Nature Communications · 2024 · PMID 38918369
  not yet assessed
• A distinct tumor microenvironment makes anaplastic thyroid cancer more lethal but immunotherapy sensitive than papillary thyroid cancer ↗

  JCI Insight · 2024 · PMID 38478516
  not yet assessed
• Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks ↗

  Nature Communications · 2024 · PMID 38609408
  not yet assessed
• New advances in the therapeutic strategy of head and neck squamous cell carcinoma: A review of latest therapies and cutting-edge research ↗

  Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 2024 · PMID 39608621
  not yet assessed
• BRAF ^V600E /p-ERK/p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer ↗

  Thyroid · 2024 · PMID 39162997
  not yet assessed
• Potential molecular mechanisms of ETV6-RUNX1-positive B progenitor cell cluster in acute lymphoblastic leukemia revealed by single-cell RNA sequencing ↗

  PeerJ · 2024 · PMID 39498293
  not yet assessed
• Targeting CDK2 Confers Vulnerability to Lenvatinib Via Driving Senescence in Anaplastic Thyroid Cancer ↗

  Advanced Science · 2024 · PMID 39716890
  not yet assessed
• An Artificial Intelligence–Driven Preoperative Radiomic Subtype for Predicting the Prognosis and Treatment Response of Patients with Papillary Thyroid Carcinoma ↗

  Clinical Cancer Research · 2024 · PMID 39535738
  not yet assessed
• Synchronous papillary and follicular thyroid carcinomas: the first retrospective cohort study and literature review ↗

  Translational Cancer Research · 2024 · PMID 38737695
  not yet assessed
• Subcutaneous implantation after endoscopic and traditional thyroid surgery: a retrospective case report ↗

  Frontiers in Oncology · 2024 · PMID 38912068
  not yet assessed
• Feasibility of the enhanced neuromuscular blockade recovery protocol with selective use of sugammadex in thyroid surgery with intraoperative neuromonitoring ↗

  Head & Neck · 2024 · PMID 38877778
  not yet assessed
• Integrated proteomics and metabolomics reveal the mechanisms of blood pressure reduction in spontaneously hypertensive rats under high-altitude hypoxic conditions ↗

  2024
  not yet assessed
• TERT accelerates BRAF mutant–induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis ↗

  Science Advances · 2023 · PMID 37647391
  not yet assessed
• TERT accelerates BRAF mutant-induced thyroid cancer dedifferentiation and progression by regulating ribosome biogenesis ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2023
  not yet assessed
• Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks ↗

  Research Square · 2023
  not yet assessed
• Integrated proteogenomic characterization of medullary thyroid carcinoma ↗

  Cell Discovery · 2022 · PMID 36344509
  not yet assessed
• Targeting Tumor Hypoxia Inhibits Aggressive Phenotype of Dedifferentiated Thyroid Cancer ↗

  The Journal of Clinical Endocrinology & Metabolism · 2022 · PMID 36190930
  not yet assessed
• Integrated single-cell and bulk RNA sequencing analyses reveal a prognostic signature of cancer-associated fibroblasts in head and neck squamous cell carcinoma ↗

  Frontiers in Genetics · 2022 · PMID 36568368
  not yet assessed
• Development and validation of a gene model predicting lymph node metastasis and prognosis of oral squamous cell carcinoma based on single‐cell and bulk <scp>RNA</scp> ‐seq analysis ↗

  Journal of Oral Pathology and Medicine · 2022 · PMID 36153671
  not yet assessed
• LncRNA-FAM66C Was Identified as a Key Regulator for Modulating Tumor Microenvironment and Hypoxia-Related Pathways in Glioblastoma ↗

  Frontiers in Public Health · 2022 · PMID 35874989
  not yet assessed
• Analysis of the key ligand receptor CADM1_CADM1 in the regulation of thyroid cancer based on scRNA-seq and bulk RNA-seq data ↗

  Frontiers in Endocrinology · 2022 · PMID 36523593
  not yet assessed
• Supplemental data for the manuscript: Targeting tumor hypoxia inhibits aggressive phenotype of dedifferentiated thyroid cancer ↗

  Figshare · 2022
  not yet assessed
• Supplemental data for the manuscript: Targeting tumor hypoxia inhibits aggressive phenotype of dedifferentiated thyroid cancer ↗

  Figshare · 2022
  not yet assessed
• Supplemental data for the manuscript: Targeting tumor hypoxia inhibits aggressive phenotype of dedifferentiated thyroid cancer ↗

  Figshare · 2022
  not yet assessed
• Single-cell transcriptomic analysis of the tumor ecosystems underlying initiation and progression of papillary thyroid carcinoma ↗

  Nature Communications · 2021 · PMID 34663816
  not yet assessed
• Cancer-Associated Fibroblasts Positively Correlate with Dedifferentiation and Aggressiveness of Thyroid Cancer ↗

  OncoTargets and Therapy · 2021 · PMID 33654411
  not yet assessed
• Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer ↗

  Acta Biochimica et Biophysica Sinica · 2021 · PMID 34693452
  not yet assessed
• Prognostic evaluation model for papillary thyroid cancer: a retrospective study of 660 cases ↗

  Gland Surgery · 2021 · PMID 34422588
  not yet assessed
• Next-Generation Sequencing Enhances the Diagnosis Efficiency in Thyroid Nodules ↗

  Frontiers in Oncology · 2021 · PMID 34322384
  not yet assessed
• Different clinicopathologic features predispose to different patterns of distant metastasis with heterogeneous short‐term prognosis in patients with differentiated thyroid cancer ↗

  Clinical Endocrinology · 2021 · PMID 34592016
  not yet assessed
• Identification of Lipid Metabolism-Related Genes as Prognostic Indicators in Papillary Thyroid Cancer ↗

  Research Square · 2021
  not yet assessed
• Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study ↗

  The Journal of Clinical Endocrinology & Metabolism · 2020 · PMID 33000173
  not yet assessed
• Genomic and Transcriptomic Characterization of Sporadic Medullary Thyroid Carcinoma ↗

  Thyroid · 2020 · PMID 32031055
  not yet assessed
• Characteristics of lipid metabolism-related gene expression-based molecular subtype in papillary thyroid cancer ↗

  Acta Biochimica et Biophysica Sinica · 2020 · PMID 32880619
  not yet assessed
• Gene expression profiling of cells of origin of squamous cell carcinomas in head-and-neck, esophagus, and lung ↗

  Acta Biochimica et Biophysica Sinica · 2020 · PMID 31960064
  not yet assessed
• Corrigendum to: Gene expression profiling of cells of origin of squamous cell carcinomas in head-and-neck, esophagus, and lung ↗

  Acta Biochimica et Biophysica Sinica · 2020 · PMID 32643758
  not yet assessed
• Multiple bone brown tumor secondary to primary hyperparathyroidism: a case report and literature review ↗

  Gland Surgery · 2019 · PMID 32042691
  not yet assessed
• The association between tumor’s location and cervical lymph nodes metastasis in papillary thyroid cancer ↗

  Gland Surgery · 2019 · PMID 31741887
  not yet assessed
• Metabolic reprogramming and its clinical application in thyroid cancer (Review) ↗

  Oncology Letters · 2019 · PMID 31423225
  not yet assessed
• Lymph node ratio (LNR) as a complementary staging system to TNM staging in salivary gland cancer ↗

  European Archives of Oto-Rhino-Laryngology · 2019 · PMID 31511971
  not yet assessed
• The critical role of RasGRP4 in the growth of diffuse large B cell lymphoma ↗

  Cell Communication and Signaling · 2019 · PMID 31409422
  not yet assessed
• Effects of tumor size on prognosis in differentiated thyroid carcinoma smaller than 2 cm ↗

  Oncology Letters · 2019 · PMID 30944617
  not yet assessed
• The application of selective neck dissection while preserving the cutaneous branches of cervical plexus in the surgical treatment of differentiated thyroid cancer—experiences from thousands of cases ↗

  Annals of Translational Medicine · 2019 · PMID 31157272
  not yet assessed
• Germline Missense Mutation of Deleted in Malignant Brain Tumor 1 (&lt;b&gt;&lt;i&gt;DMBT1&lt;/i&gt;&lt;/b&gt;) in Familial Mediastinal Neuroendocrine Cancer and in vitro Effects in Thyroid Cancer Cells ↗

  Neuroendocrinology · 2019 · PMID 31655821
  not yet assessed
• The Application of Hemithyroidectomy Plus Central Neck Dissection in the Initial Surgical Treatment of Papillary Thyroid Microcarcinoma ↗

  VideoEndocrinology · 2019
  not yet assessed
• A Quantitative Research on the Influence of Music Trait on Short-term Memory of College Students

  2019 5th International Workshop on Education, Development and Social Sciences · 2019
  not yet assessed
• Supplementary Material for: Germline Missense Mutation of Deleted in Malignant Brain Tumor 1 (<b><i>DMBT1</i></b>) in Familial Mediastinal Neuroendocrine Cancer and in vitro Effects in Thyroid Cancer Cells ↗

  Figshare · 2019
  not yet assessed
• Histone methyltransferase KMT5A gene modulates oncogenesis and lipid metabolism of papillary thyroid cancer in�vitro ↗

  Oncology Reports · 2018 · PMID 29512765
  not yet assessed
• Downregulation of <scp>CSN</scp>6 attenuates papillary thyroid carcinoma progression by reducing Wnt/<i>β</i>‐catenin signaling and sensitizes cancer cells to <scp>FH</scp>535 therapy ↗

  Cancer Medicine · 2018 · PMID 29341469
  not yet assessed
• Lingual ectopic papillary thyroid carcinoma: Two case reports and review of the literature ↗

  Oral Oncology · 2018 · PMID 30473413
  not yet assessed
• NRG1 regulates redox homeostasis via NRF2 in papillary thyroid cancer ↗

  International Journal of Oncology · 2018 · PMID 29901070
  not yet assessed
• SIRT6 is upregulated and associated with cancer aggressiveness in papillary thyroid cancer via BRAF/ERK/Mcl-1 pathway ↗

  International Journal of Oncology · 2017 · PMID 28393212
  not yet assessed
• The impact of presence of Hashimoto's thyroiditis on diagnostic accuracy of ultrasound‐guided fine‐needle aspiration biopsy in subcentimeter thyroid nodules: A retrospective study from FUSCC ↗

  Cancer Medicine · 2017 · PMID 28382784
  not yet assessed
• Mediastinal Lymph Node Metastases in Thyroid Cancer: Characteristics, Predictive Factors, and Prognosis ↗

  International Journal of Endocrinology · 2017 · PMID 29259627
  not yet assessed
• Aberrant hypermethylation of the HOXD10 gene in papillary thyroid cancer with BRAFV600E mutation ↗

  Oncology Reports · 2017 · PMID 29115628
  not yet assessed
• [Risk for metastasis of lymph node between sternocleidomastoid and sternohyoid muscle in papillary thyroid cancer]. ↗

  PubMed · 2017 · PMID 28441800
  not yet assessed
• Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence ↗

  Thyroid · 2016 · PMID 27825291
  not yet assessed
• BRAF-activated LncRNA functions as a tumor suppressor in papillary thyroid cancer ↗

  Oncotarget · 2016 · PMID 27462868
  not yet assessed
• The impact of marital status at diagnosis on cancer survival in patients with differentiated thyroid cancer ↗

  Cancer Medicine · 2016 · PMID 27264532
  not yet assessed
• Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer ↗

  Tumor Biology · 2016 · PMID 26743781
  not yet assessed
• The Trend of Age-Group Effect on Prognosis in Differentiated Thyroid Cancer ↗

  Scientific Reports · 2016 · PMID 27272218
  not yet assessed
• Yes-associated protein 1 promotes papillary thyroid cancer cell proliferation by activating the ERK/MAPK signaling pathway ↗

  Oncotarget · 2016 · PMID 28036290
  not yet assessed
• Metastatic lymph node ratio can further stratify risk for mortality in medullary thyroid cancer patients: A population-based analysis ↗

  Oncotarget · 2016 · PMID 27588396
  not yet assessed
• Prognostic significance and optimal cutoff of age in medullary thyroid cancer ↗

  Oncotarget · 2016 · PMID 26910117
  not yet assessed
• DUSP4/MKP2 overexpression is associated with BRAFV600E mutation and aggressive behavior of&amp;nbsp;papillary thyroid cancer ↗

  OncoTargets and Therapy · 2016 · PMID 27143921
  not yet assessed
• Cloning, characterization, and expression analysis of LGP2 cDNA from goose, Anser cygnoides ↗

  Poultry Science · 2016 · PMID 27143779
  not yet assessed
• The impact of high co-expression of Sp1 and HIF1α on prognosis of patients with hepatocellular cancer ↗

  Oncology Letters · 2016 · PMID 27347172
  not yet assessed
• Primary synovial sarcoma of the thyroid with locally repeated relapses in short periods: A case report ↗

  Biomedical Reports · 2016 · PMID 27330751
  not yet assessed
• Relationship of body mass index with BRAF V600E mutation in papillary thyroid cancer ↗

  Tumor Biology · 2016 · PMID 26733165
  not yet assessed
• Expression, clinical significance and mechanism of Slit2 in papillary thyroid cancer ↗

  International Journal of Oncology · 2016 · PMID 26935705
  not yet assessed
• Primary chondrosarcoma of the thyroid cartilage: Surgery-based management of a rare case ↗

  Oncology Letters · 2016 · PMID 28101206
  not yet assessed
• [The model of specialized training for diagnosis and treatment in thyroid cancer]. ↗

  PubMed · 2016 · PMID 27666699
  not yet assessed
• Risk Factors for Central Compartment Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: A Meta‐Analysis ↗

  World Journal of Surgery · 2015 · PMID 26099728
  not yet assessed
• The impact of coexistent Hashimoto’s thyroiditis on lymph node metastasis and prognosis in papillary thyroid microcarcinoma ↗

  Tumor Biology · 2015 · PMID 26692097
  not yet assessed
• Preoperative ultrasonography and serum thyroid-stimulating hormone on predicting central lymph node metastasis in thyroid nodules as or suspicious for papillary thyroid microcarcinoma ↗

  Tumor Biology · 2015 · PMID 26678888
  not yet assessed
• Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature ↗

  Tumor Biology · 2015 · PMID 26695148
  not yet assessed
• The Usefulness of Preoperative Thyroid‐Stimulating Hormone for Predicting Differentiated Thyroid Microcarcinoma ↗

  Otolaryngology · 2015 · PMID 26598500
  not yet assessed
• The Prediction of Sonographic features and BRAF Mutation for Central Lymph Node Metastasis in Papillary Thyroid Microcarcinoma: Reply ↗

  World Journal of Surgery · 2015 · PMID 26493695
  not yet assessed
• Number of tumor foci predicts prognosis in papillary thyroid cancer ↗

  BMC Cancer · 2014 · PMID 25471041
  not yet assessed
• Risk of malignancy in focal thyroid lesions identified by 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography: evidence from a large series of studies ↗

  Tumor Biology · 2014 · PMID 24622887
  not yet assessed
• Expression of microRNA-142-3p and RAC1mRNA in colorectal cancer tissues and its clinical significance ↗

  2013
  not yet assessed
• Mammographic Findings in 54 Cases with Breast Invasive Ductal Carcinoma

  Journal of Oncology · 2007
  not yet assessed